Thanks to advances in genetic engineering and biotech, biofabrication has moved from science fiction to practical, real world applications over the past decade. Expect to see more advances and more use of biofabed materials in the near future. ...
The medical innovation areas covered include genomics, biotech pharmaceuticals and digital health records. Interesting quote on genomics: "The cost of sequencing a human genome has fallen considerably over the past few years, enabling research that not so long ago was cost prohibitive. As a result,...
small molecule cancer treatment tempest therapeutics is a clinical-stage biotech developing small molecule therapy to treat cancer. ceo stephen brady joined us to discuss clinical studies, partnering with roche and how he thinks about licensing and m&a. allowing the immune system to do its j...
“oh the market is too expensive, the market is too expensive”. Now we would agree with that with certain pockets of the market, and certainly what we have seen with technology companies, healthcare, biotech, they are expensive, no doubt about it. But on...
Posted in 483 observations, Agriculture, Ammonia plants, Biotech, Bull market, China, Cloud Computing, Commercial banks, community banks, Congress, Defense cutbacks, Economic recovery, Entitlement reform, FDA, Fertilizers, Financial services, GDP growth, Hedge funds, High tech, Home building, Infrastr...
Our research is solid and focused on small to mid cap growth companies In addition to growth; we love artificial intelligence, chart plays, swing trades, low float potential breakout stocks, new technology and biotech breakthrough’s. There is only one way to see and feel the difference. Join...
Amit Shah, age 53, has served as a senior financial officer for a number of life science companies, including Chief Financial Officer at Marina Biotech, Inc., a publicly traded biotechnology company (2017 to 2018); Vice President of Finance & Accounting and Acting Chief Financial Officer at In...
Opponents point out that yields are sometimes reduced and pesticide use increased because the biotech companies have concentrated on developing plant varieties that can endure heavier use of their own pesticides. Pembrokeshire farmer Walter Simon believes the Prince has a point over future access to ...
"Learn the lessons of the biotech revolution and lobby the Bush administration to regulate nano now under the guidance of the National Academy of Sciences using existing EPA and FDA authority." E. Donald Elliott Chair, Environment, Health and Safety Department Willkie Farr & Gallagher LLP "The ...
Unlike traditional pharma or biotech companies, most of the people working at Nimbus Therapeutics are gig workers. And the primary reason Nimbus hires gig workers is not to cut costs. It's to increase their business flexibility and agility and access hard to find, highly skilled talent. Acco...